|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1482888203 |
| 003 |
DE-627 |
| 005 |
20230426123118.0 |
| 007 |
tu |
| 008 |
140825s2014 xx ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)1482888203
|
| 035 |
|
|
|a (DE-576)412888203
|
| 035 |
|
|
|a (DE-599)BSZ412888203
|
| 035 |
|
|
|a (OCoLC)889988290
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 100 |
1 |
|
|a Halama, Birte
|d 1986-
|0 (DE-588)1034229117
|0 (DE-627)745127509
|0 (DE-576)381858553
|4 aut
|
| 242 |
1 |
0 |
|a Heidelberg, Univ., Diss., 2014
|y eng
|
| 245 |
1 |
0 |
|a Nanodose study of the CYP3A paradigm substrate midazolam to evaluate pharmacokinetic linearity of parent drug before and during CYP3A inhibition
|c vorgelegt von Birte Halama
|
| 264 |
|
1 |
|c 2014
|
| 300 |
|
|
|a IX, 64 Bl.
|b graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 856 |
4 |
2 |
|u http://d-nb.info/1055013768/04
|m B:DE-101
|q application/pdf
|3 Inhaltsverzeichnis
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20141211
|
| 993 |
|
|
|a Thesis
|
| 994 |
|
|
|a 2014
|
| 998 |
|
|
|g 1034229117
|a Halama, Birte
|m 1034229117:Halama, Birte
|d 50000
|d 51001
|e 50000PH1034229117
|e 51001PH1034229117
|k 0/50000/
|k 1/50000/51001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1482888203
|e 2826226592
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"physDesc":[{"extent":"IX, 64 Bl.","noteIll":"graph. Darst."}],"type":{"bibl":"thesis"},"language":["eng"],"recId":"1482888203","person":[{"display":"Halama, Birte","role":"aut","family":"Halama","given":"Birte"}],"name":{"displayForm":["vorgelegt von Birte Halama"]},"origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"title":[{"title_sort":"Nanodose study of the CYP3A paradigm substrate midazolam to evaluate pharmacokinetic linearity of parent drug before and during CYP3A inhibition","title":"Nanodose study of the CYP3A paradigm substrate midazolam to evaluate pharmacokinetic linearity of parent drug before and during CYP3A inhibition"}],"id":{"eki":["1482888203"]}}
|
| SRT |
|
|
|a HALAMABIRTNANODOSEST2014
|
